Amanote Research

Amanote Research

    RegisterSign In

Targeted Cancer Therapy With Ribosome Biogenesis Inhibitors: A Real Possibility?

Oncotarget - United States
doi 10.18632/oncotarget.5775
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

September 22, 2015

Authors
Elisa BrighentiDavide TreréMassimo Derenzini
Publisher

Impact Journals, LLC


Related search

A Liaison Between mTOR Signaling, Ribosome Biogenesis and Cancer

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
BiochemistryGeneticsStructural BiologyMolecular BiologyBiophysics
2015English

Selective Inhibitors for JNK Signalling: A Potential Targeted Therapy in Cancer

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2020English

Ribosome Biogenesis Factors Working With a Nuclear Envelope SUN Domain Protein

Nucleus
MedicineCell Biology
2012English

Targeted Cancer Therapy: Interactions With Other Medicines

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2016English

Bystin in Human Cancer Cells: Intracellular Localization and Function in Ribosome Biogenesis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2007English

Diamond Blackfan Anemia and Ribosome Biogenesis: Introduction

Seminars in Hematology
Hematology
2011English

Ribosome Biogenesis in the Yeast Saccharomyces Cerevisiae

Genetics
Genetics
2013English

Targeted Therapy in Gastric Cancer

European Surgery - Acta Chirurgica Austriaca
Surgery
2016English

Ribosomal DNA-connecting Ribosome Biogenesis and Chromosome Biology

Chromosome Research
Genetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy